Johns Hopkins
Researchers Aim to Confirm Benefits of Non-Hormonal Therapy for Certain Prostate Cancer Patients
Premium
Prostate cancer patients with BRCA2 and other homologous recombination repair mutations fared better on Lynparza than those without genomic alterations.
Tumor Forecasting Using Mechanistic Rules of Biology May Improve Predictive Models, Study Suggests
Premium
Incorporating mathematical biological rules into spatial models of tumor response can yield insights into tumor progression and response, early study shows.
Spotlight on Lp(a) Risks, Low Testing Prevalence, and Potential Treatments at Cardiology Meeting
Premium
At ACC's annual meeting, there was a big focus on educating doctors about Lp(a) testing and its role in heart disease as new drugs advance in clinical trials.
Clasp Therapeutics Launches With $150M to Develop More Precise T-Cell Engagers
The firm is using an approach developed by Johns Hopkins researchers and founders, which involves redirecting patients' T cells to target their tumors.
Johns Hopkins Team Debuts Method for Genome-Wide Detection of Cancer-Linked Repeat Sequences
Premium
The approach allows a much broader survey and quantification of alterations to repeat elements of the genome, which authors found could help detect cancers.